Literature DB >> 3055806

Experimental glomerular tissue injury induced by immunization with cultured endothelial cell plasma membrane.

M Matsuda1.   

Abstract

Damage to glomerular endothelial cells, which are the constituents of the size-dependent and charge-dependent glomerular barrier, may result in proteinuria. Brain endothelial cell plasma membrane possesses an intrinsic potential antigenicity which is capable of injuring the blood-brain barrier and causing widespread demyelination in the brain. To examine the pathogenetic effect on the glomerulus of plasma membrane sensitization, we injected guinea pigs with a single dose of plasma membrane products derived from cultured endothelial cells from the brain and umbilical cord, and observed the resulting effects both clinically and by histological, immunofluorescence and ultrastructural examinations of renal tissues. The animals immunized with plasma membrane products showed clinically mild proteinuria. Proliferative changes in the mesangial matrix with mild mononuclear cell infiltration was observed in the glomeruli of all experimental animals. Immunofluorescence studies showed finely granular, peripheral capillary loop and mesangial staining for IgG and C3. Electron microscopy revealed fine, electron-dense deposits in the subendothelial region. In addition, titers of anti-endothelial cell antibodies and circulating immune complexes were significantly high. It was suggested that antibody-mediated immune mechanisms might play a role in the pathogenesis of this glomerular tissue injury induced by immunization with cultured endothelial cell plasma membrane products.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3055806     DOI: 10.1111/j.1440-1827.1988.tb02355.x

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN: 0001-6632


  8 in total

Review 1.  Antiendothelial cell antibodies in vasculitis and connective tissue disease.

Authors:  C Belizna; A Duijvestijn; M Hamidou; J W Cohen Tervaert
Journal:  Ann Rheum Dis       Date:  2006-03-28       Impact factor: 19.103

Review 2.  Antiendothelial cell antibodies (AECA) in systemic lupus erythematosus (SLE).

Authors:  D D'Cruz; M Khamashta; G Hughes
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

3.  Soluble thrombomodulin and antibodies to bovine glomerular endothelial cells in patients with Henoch-Schönlein purpura.

Authors:  M Fujieda; N Oishi; K Naruse; M Hashizume; K Nishiya; T Kurashige; K Ito
Journal:  Arch Dis Child       Date:  1998-03       Impact factor: 3.791

4.  Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis.

Authors:  D P D'Cruz; F A Houssiau; G Ramirez; E Baguley; J McCutcheon; J Vianna; H J Haga; G T Swana; M A Khamashta; J C Taylor
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

5.  Alterations in the Liver Fat Fraction Features Examined by Magnetic Resonance Imaging Following Bariatric Surgery: a Self-Controlled Observational Study.

Authors:  Mengyi Li; Di Cao; Yang Liu; Lan Jin; Na Zeng; Lixue Wang; Kaixin Zhao; Han Lv; Meng Zhang; Peng Zhang; Zhenghan Yang; Zhongtao Zhang
Journal:  Obes Surg       Date:  2020-05       Impact factor: 4.129

Review 6.  Design of universal cancer vaccines using natural tumor vessel-specific antigens (SANTAVAC).

Authors:  Petr G Lokhov; Elena E Balashova
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

7.  Allogeneic Antigen Composition for Preparing Universal Cancer Vaccines.

Authors:  Petr G Lokhov; Elena E Balashova
Journal:  J Immunol Res       Date:  2016-10-03       Impact factor: 4.818

8.  SANTAVAC ™: A Novel Universal Antigen Composition for Developing Cancer Vaccines.

Authors:  Petr G Lokhov; Elena E Balashova
Journal:  Recent Pat Biotechnol       Date:  2017
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.